Business / Finance RSS Feed - Business / Finance

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Biogen Idec Inc. today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013. [More]
NeoGenomics' revenue up 16.1% in first quarter 2014

NeoGenomics' revenue up 16.1% in first quarter 2014

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014. [More]

Natus Medical reports revenue of $85.6 million in first quarter 2014

Natus Medical Incorporated today announced financial results for the three months ended March 31, 2014. [More]
Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology, today announced it has completed a $22.5 million Series B financing. [More]
DaVita Kidney Care expands care of kidney patients in Malaysia

DaVita Kidney Care expands care of kidney patients in Malaysia

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced it acquired three hemodialysis centers from Malaysian dialysis provider Sinar Indentiti Sbn Bhd, further expanding its care of kidney patients in the country. [More]

Diaverum acquires its seventh kidney centre in Chile

Diaverum, one of the world's leading renal care service providers, has acquired its seventh kidney centre Chile. The Diaseal clinic, located in Puente Alto, a highly populated and fast growing district in the south of capital Santiago, features 18 stations which are used to treat 100 patients with haemodialysis (HD). [More]

Spire Leeds Hospital invests £200,000 in PENTAX Medical’s HD+ endoscopes

Spire Leeds Hospital has invested almost £200,000 in state-of-the-art endoscopy equipment from PENTAX Medical – which will benefit local patients. The extraordinarily high resolution images that the new equipment provides will help enhance the hospital’s detection of diseases, such as cancer, and enable earlier treatment which can improve patient outcomes. [More]

STEM-Pharma delivers evidence-based recommendations on pharmaceutical growth in emerging markets

STEM-Pharma is a management consulting firm specialized in healthcare and pharmaceutical market intelligence. The company delivers evidence-based recommendations on pharmaceutical growth opportunities in emerging markets. [More]

MTA, TAITRA and WMTC partner to showcase Taiwan's medical tourism industry

The Medical Tourism Association (MTA), the Ministry of Health & Welfare, Taiwan and the Taiwan External Trade Development Council (TAITRA) have joined together on two strategic initiatives designed to showcase Taiwan's top-rated healthcare system and booming medical tourism industry. [More]

AMSBIO opens new North American headquarters

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC. [More]

EPSRC to invest £83.5M in UK universities through Doctoral Training Partnerships

Postgraduate training in the UK's universities is to receive another injection of funding from The Engineering and Physical Sciences Research Council (EPSRC). [More]
Northern Ireland expands PACS contract with Sectra to include digital breast imaging

Northern Ireland expands PACS contract with Sectra to include digital breast imaging

The department of Health, Social Services and Public Safety in Northern Ireland has expanded its PACS contract with Sectra, to include digital breast imaging. [More]
Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock. [More]

Quest Diagnostics acquires Summit Health

Quest Diagnostics, the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health, a leading provider of on-site prevention and wellness services. Financial terms were not disclosed. [More]
Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR). [More]
MEDNAX acquires Fredericksburg Anesthesia Associates

MEDNAX acquires Fredericksburg Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Fredericksburg Anesthesia Associates, Inc., a private practice physician group based in Fredericksburg, Va. The practice will become part of MEDNAX's American Anesthesiology division and is the third Virginia-based anesthesia practice to join the division. [More]

Healthbox closes $7M in funding to execute new business priorities

Today Healthbox announces it has closed $7 million in funding to expand on its accelerator model and launch three new business verticals that will continue to drive actionable innovation through collaboration between entrepreneurs and the healthcare industry. [More]

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on proprietary macrocyclic chemistry, today announced the signing of a discovery and co-development agreement with Southern Research Institute, a not-for-profit 501(c)(3) scientific research organization founded in 1941. [More]
Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013. [More]
FTC requests additional information relating to Actavis’ pending acquisition of Forest Laboratories

FTC requests additional information relating to Actavis’ pending acquisition of Forest Laboratories

Actavis plc and Forest Laboratories, Inc. today announced that they have each received a request for additional information from the Federal Trade Commission ("FTC") in connection with Actavis' pending acquisition of Forest. [More]